Use of terfenadine and contraindicated drugs

JAMA

Volumn 275, Issue 17, 1996, Pages 1339-1341

  Thompson, David ^a   Oster, Gerry ^a  

^a POLICY ANALYSIS INC PAI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CLARITHROMYCIN; ERYTHROMYCIN; ITRACONAZOLE; KETOCONAZOLE; MACROLIDE; TERFENADINE; TROLEANDOMYCIN;

ARTICLE; COMPUTER SYSTEM; DRUG CONTRAINDICATION; DRUG LABELING; HUMAN; PATIENT EDUCATION; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0029925607     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.17.1339     Document Type: Article

References (16)

1. Masheter HC. Terfenadine: the first nonsedating antihistamine. Clin Rev Allergy. 1993;11:5-34.
2. IMS America Ltd. 1995 National Prescription Audit. Plymouth Meeting, Pa: IMS America Ltd; 1995.
3. Marion Merrell Dow Inc. Important Drug Warning. Cincinnati, Ohio: Marion Merrell Dow Inc; August 6, 1990.
4. Pulmonary- Allergy Drugs Advisory Committee. Proceedings of the Pulmonary-Allergy Drugs Advisory Committee. Rockville, Md: Food and Drug Administration, Public Health Service, US Dept of Health and Human Services; 1990.
5. Marion Merrell Dow Inc. Important Drug Warning. Kansas City, Mo: Marion Merrell Dow Inc; July 1992.
6. Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR. Torsades de pointes occurring in association with terfenadine use. JAMA. 1990;264:2788-2790.
7. Crane JK, Shih H-T. Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine. Am J Med. 1993;95:445-446.
8. Nightingale SL. Warnings issued on nonsedating antihistamines terfenadine and astemizole. JAMA. 1992;268:705.
9. Peck CC, Temple R, Collins JM. Understanding consequences of concurrent therapies. JAMA. 1993; 269:1550-1552.
10. Safety of terfenadine and astemizole. Med Lett Drugs Ther. 1992;34:9-10.
11. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther. 1992;52:231-238.
12. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences. JAMA. 1983;269:1513-1518.
13. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA. 1993;269:1535-1539.
14. Honig PK, Wortham DC, Hull R, Zamani K, SmithJE, Cantilena LR. Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics. J Clin Pharmacol. 1993;33:1201-1206.
15. Marion Merrell Dow Inc. Seldane Product Labeling. Kansas City, Mo: Marion Merrell Dow Inc; 1993.
16. Cavuto NJ, Woosley RL, Sale M, Bates DW, Leape LL. Pharmacies and prevention of potentially fatal drug interactions. JAMA. 1996;275:1086-1087.